Bio-Tree Systems, based in Providence, RI, is the pioneering inventor of the AI Machine Learning Machine Vision-based Vasculomics Platform, a cutting-edge technology designed to analyze 3D datasets from various tomographic scanners. This innovative platform enables precise geometric and morphologic analysis of organ-specific 3D micro-vascular trees, facilitating early detection of organ diseases and contributing to the emerging field of Digital Health Precision Medicine.
With a focus on the Ophthalmology industry, Bio-Tree offers OptoTree, a solution aimed at the early detection of Diabetic Retinopathy. Additionally, their Bio-Tree PreClin product targets the Oncology drug discovery industry, with plans for expansion into other pre-clinical markets. By leveraging their analytical micro-vascular metrics, initially developed for tumor angiogenesis analysis in oncology, Bio-Tree's technology can effectively detect organ-specific diseases expressed through abnormal micro-vascular patterns.
Generated from the website